Aytu BioScience, Inc. (AYTU) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.58, down from yesterday’s close by -7.10%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Aytu BioScience, Inc. (AYTU) currently trades with a market capitalization of $13.80 Million. That value represents a market adjusting for revenues that have been growing by 32.36 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$13.06 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$1 on a per share basis this quarter. Perhaps, that suggests something about why 26.80% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Aytu BioScience, Inc. recorded a 52-week high of $16.00. It is now trading 15.42% off that level. The stock is trading $1.04 its 50-day moving average by 0.46%. The stock carved out a 52-week low down at $0.38.
In recent action, Aytu BioScience, Inc. (AYTU) has made a move of +41.46% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.08, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.03% with $21.29 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AYTU.